ロード中...
Current and Future Directions for PARP Inhibition
Megan Grudem, APRN, CNP, and Andrea Wahner Hendrickson, MD, reviewed the potential role of PARP inhibition in various malignancies, how to select patients who are appropriate candidates, and guidance on devising treatment plans that include PARP inhibitors for patients with ovarian or breast cancer...
保存先:
| 出版年: | J Adv Pract Oncol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Harborside Press LLC
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7857320/ https://ncbi.nlm.nih.gov/pubmed/33598329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2020.11.3.16 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|